Identifikatu
Taldeak
Ikertzaileak
Emaitzak
HOSPITAL UNIVERSITARIO RUBER
Saila
First Hospital of Jilin University
Changchun, China
Hemen zaude
Lankidetzak
First Hospital of Jilin University
First Hospital of Jilin University-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2023
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117
2016
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
ca
gl
en
fr
de